Paper28296232
Inhibitors of soluble epoxide hydrolase minimize ischemia-reperfusion-induced cardiac damage in normal, hypertensive, and diabetic rats.
Islam O and 10 others. Cardiovasc Ther, 2017. Cited by 25 papers, by iCite.
Cite this record
ConductScience Library. Inhibitors of soluble epoxide hydrolase minimize ischemia-reperfusion-induced cardiac damage in normal, hypertensive, and diabetic rats. Papers, record 28296232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28296232
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Inhibitors of soluble epoxide hydrolase minimize ischemia-reperfusion-induced cardiac damage in normal, hypertensive, and diabetic rats.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Benzoates | Major topic |
| Diabetes Mellitus, Experimental | Major topic |
| Diabetes Mellitus, Type 1 | Major topic |
| Enzyme Inhibitors | Major topic |
| Epoxide Hydrolases | Major topic |
| Hypertension | Major topic |
| Myocardial Reperfusion Injury | Major topic |
| Myocardium | Major topic |
| Phenylurea Compounds | Major topic |
| Piperidines | Major topic |
| Animals | |
| Aorta, Thoracic | |
| Dose-Response Relationship, Drug | |
| Heart Rate | |
| Isolated Heart Preparation | |
| Male | |
| Myocardial Contraction | |
| Myocardial Infarction | |
| Rats, Wistar | |
| Vasodilation |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P42 ES004699 | NIEHS NIH HHS | United States | P42ES004699 | PubMed and NIH | NIH RePORTER |
| R01 ES002710 | NIEHS NIH HHS | United States | R01ES002710 | PubMed and NIH | NIH RePORTER |
References55
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25827057 | Inhibition of soluble epoxide hydrolase attenuates hepatic fibrosis and endoplasmic reticulum stress induced by carbon tetrachloride in mice. | Toxicol Appl Pharmacol | 2015 | https://conductscience.org/library/papers/25827057 | PubMed |
| 2 | 16157792 | An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension. | Hypertension | 2005 | https://conductscience.org/library/papers/16157792 | PubMed |
| 3 | 484502 | The metabolic demand and oxygen supply of the heart: physiologic and clinical considerations. | Am J Cardiol | 1979 | https://conductscience.org/library/papers/484502 | PubMed |
| 4 | 27795806 | C1q/TNF-Related Protein 9 Protects Diabetic Rat Heart against Ischemia Reperfusion Injury: Role of Endoplasmic Reticulum Stress. | Oxid Med Cell Longev | 2016 | https://conductscience.org/library/papers/27795806 | PubMed |
| 5 | 6109858 | Heart rate changes in diabetes mellitus. | Lancet | 1981 | https://conductscience.org/library/papers/6109858 | PubMed |
| 6 | 9686693 | Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. | Diabet Med | 1998 | https://conductscience.org/library/papers/9686693 | PubMed |
| 7 | 25295006 | Epoxyeicosatrienoic acid analog attenuates angiotensin II hypertension and kidney injury. | Front Pharmacol | 2014 | https://conductscience.org/library/papers/25295006 | PubMed |
| 8 | 27932512 | ATF6 Decreases Myocardial Ischemia/Reperfusion Damage and Links ER Stress and Oxidative Stress Signaling Pathways in the Heart. | Circ Res | 2017 | https://conductscience.org/library/papers/27932512 | PubMed |
| 9 | 16330695 | Cardiovascular disease in the developing world and its cost-effective management. | Circulation | 2005 | https://conductscience.org/library/papers/16330695 | PubMed |
| 10 | 18479281 | The relationship between endothelial dysfunction and oxidative stress in diabetes and prediabetes. | Int J Clin Pract | 2008 | https://conductscience.org/library/papers/18479281 | PubMed |
| 11 | 19755525 | Endoplasmic reticulum stress in diabetic hearts abolishes erythropoietin-induced myocardial protection by impairment of phospho-glycogen synthase kinase-3beta-mediated suppression of mitochondrial permeability transition. | Diabetes | 2009 | https://conductscience.org/library/papers/19755525 | PubMed |
| 12 | 26989141 | Anti-Ulcer Efficacy of Soluble Epoxide Hydrolase Inhibitor TPPU on Diclofenac-Induced Intestinal Ulcers. | J Pharmacol Exp Ther | 2016 | https://conductscience.org/library/papers/26989141 | PubMed |
| 13 | 12700580 | The imbalance between oxygen demand and supply as a potential mechanism in the pathophysiology of heart failure: the role of microvascular growth and abnormalities. | Microcirculation | 2003 | https://conductscience.org/library/papers/12700580 | PubMed |
| 14 | 26109894 | Cardiovascular effects of high-fructose intake in rats with nitric oxide deficiency. | Interdiscip Toxicol | 2014 | https://conductscience.org/library/papers/26109894 | PubMed |
| 15 | 27732913 | Targeting arachidonic acid pathway to prevent programmed hypertension in maternal fructose-fed male adult rat offspring. | J Nutr Biochem | 2016 | https://conductscience.org/library/papers/27732913 | PubMed |
| 16 | 23247129 | Beneficial effects of inhibition of soluble epoxide hydrolase on glucose homeostasis and islet damage in a streptozotocin-induced diabetic mouse model. | Prostaglandins Other Lipid Mediat | 2013 | https://conductscience.org/library/papers/23247129 | PubMed |
| 17 | 21266668 | Soluble epoxide hydrolase in the generation and maintenance of high blood pressure in spontaneously hypertensive rats. | Am J Physiol Endocrinol Metab | 2011 | https://conductscience.org/library/papers/21266668 | PubMed |
| 18 | 25574192 | Endoplasmic reticulum stress response in spontaneously hypertensive rats is affected by myocardial ischemia reperfusion injury. | Exp Ther Med | 2015 | https://conductscience.org/library/papers/25574192 | PubMed |
| 19 | 9673301 | Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. | N Engl J Med | 1998 | https://conductscience.org/library/papers/9673301 | PubMed |
| 20 | 25897251 | Streptozotocin-induced type 1 diabetes in rodents as a model for studying mitochondrial mechanisms of diabetic β cell glucotoxicity. | Diabetes Metab Syndr Obes | 2015 | https://conductscience.org/library/papers/25897251 | PubMed |
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42325786 | Analysis of the effectiveness of the myocardial work index in the assessment of cancer therapy-related cardiac dysfunction. | Am J Transl Res | 2026 | https://conductscience.org/library/papers/42325786 | PubMed |
| 40139878 | Unraveling "Hot Phases" of Arrhythmogenic Cardiomyopathy. | JACC Basic Transl Sci | 2025 | https://conductscience.org/library/papers/40139878 | PubMed |
| 39703395 | The role of CYP-sEH derived lipid mediators in regulating mitochondrial biology and cellular senescence: implications for the aging heart. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/39703395 | PubMed |
| 37288113 | Characterization of 15 CYP2J2 variants identified in the Chinese Han population on the metabolism of ebastine and terfenadine in vitro. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/37288113 | PubMed |
| 36518097 | Exploration of the Mechanism of Linoleic Acid Metabolism Dysregulation in Metabolic Syndrome. | Genet Res (Camb) | 2022 | https://conductscience.org/library/papers/36518097 | PubMed |
| 36035373 | Targeting IRE1α-JNK-c-Jun/AP-1-sEH Signaling Pathway Improves Myocardial and Coronary Endothelial Function Following Global Myocardial Ischemia/Reperfusion. | Int J Med Sci | 2022 | https://conductscience.org/library/papers/36035373 | PubMed |
| 35078036 | Anthracycline derivatives inhibit cardiac CYP2J2. | J Inorg Biochem | 2022 | https://conductscience.org/library/papers/35078036 | PubMed |
| 34863976 | Epoxylipids and soluble epoxide hydrolase in heart diseases. | Biochem Pharmacol | 2022 | https://conductscience.org/library/papers/34863976 | PubMed |
| 32827665 | Cytochrome P450-derived linoleic acid metabolites EpOMEs and DiHOMEs: a review of recent studies. | J Nutr Biochem | 2020 | https://conductscience.org/library/papers/32827665 | PubMed |
| 32503253 | Bioactive Lipid Signaling in Cardiovascular Disease, Development, and Regeneration. | Cells | 2020 | https://conductscience.org/library/papers/32503253 | PubMed |
| 32475311 | Epoxy Fatty Acids: From Salt Regulation to Kidney and Cardiovascular Therapeutics: 2019 Lewis K. Dahl Memorial Lecture. | Hypertension | 2020 | https://conductscience.org/library/papers/32475311 | PubMed |
| 31773097 | Phloroglucinol, a nutraceutical for IR-induced cardiac damage in diabetic rats. | Animal Model Exp Med | 2019 | https://conductscience.org/library/papers/31773097 | PubMed |
| 31572788 | Drug-Target Residence Time Affects in Vivo Target Occupancy through Multiple Pathways. | ACS Cent Sci | 2019 | https://conductscience.org/library/papers/31572788 | PubMed |
| 31222024 | Prophylactic inhibition of soluble epoxide hydrolase delays onset of nephritis and ameliorates kidney damage in NZB/W F1 mice. | Sci Rep | 2019 | https://conductscience.org/library/papers/31222024 | PubMed |
| 31102913 | Impact of diabetes on male sexual function in streptozotocin-induced diabetic rats: Protective role of soluble epoxide hydrolase inhibitor. | Biomed Pharmacother | 2019 | https://conductscience.org/library/papers/31102913 | PubMed |
| 31068802 | Docosahexaenoic Acid Increases the Potency of Soluble Epoxide Hydrolase Inhibitor in Alleviating Streptozotocin-Induced Alzheimer's Disease-Like Complications of Diabetes. | Front Pharmacol | 2019 | https://conductscience.org/library/papers/31068802 | PubMed |
| 29966295 | Regulation of CYP2J2 and EET Levels in Cardiac Disease and Diabetes. | Int J Mol Sci | 2018 | https://conductscience.org/library/papers/29966295 | PubMed |
| 29751149 | An inhibitor of soluble epoxide hydrolase ameliorates diabetes-induced learning and memory impairment in rats. | Prostaglandins Other Lipid Mediat | 2018 | https://conductscience.org/library/papers/29751149 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| EPHX2 | 2053 | PubTator's text mining | https://conductscience.org/library/genes/2053 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28296232
GET https://conductscience.org/api/papers/v1/28296232/references?page=2